Krystal Biotech, Inc.
KRYS • NASDAQ
Krystal Biotech, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Krish S. Krishnan, with a market cap of $7.6B.
Market Cap$7.6B
Employees229.0
CEOKrish S. Krishnan
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
Krystal Biotech, Inc. FAQ
Common questions about Krystal Biotech, Inc.
Krystal Biotech, Inc. is scheduled to report earnings for Q1 2026 on May 5, 2026. Analysts estimate revenue of $112.2M.
Krystal Biotech, Inc. has approximately 229 employees.